Swainsonine, an inhibitor of mannosidase II during glycoprotein processing, enhances concanavalin A-induced T cell proliferation and interleukin 2 receptor expression exclusively via the T cell receptor complex
- 1 October 1991
- journal article
- Published by Elsevier in Cellular Immunology
- Vol. 137 (1) , 111-117
- https://doi.org/10.1016/0008-8749(91)90061-f
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Swainsonine, an Inhibitor of Glycoprotein Processing, Enhances Cytotoxicity of Large Granular LymphocytesScandinavian Journal of Immunology, 1990
- Swainsonine, an inhibitor of glycoprotein processing, enhances mitogen induced interleukin 2 production and receptor expression in human lymphocytesBiochemical and Biophysical Research Communications, 1988
- Stimulation of DNA synthesis in murine lymphocytes by the drug swainsonine: Immunomodulatory propertiesBiochemical and Biophysical Research Communications, 1988
- Evidence for a physical association of CD4 and the CD3: α : β T-cell receptorNature, 1987
- INHIBITORS OF THE BIOSYNTHESIS AND PROCESSING OF N-LINKED OLIGOSACCHARIDE CHAINSAnnual Review of Biochemistry, 1987
- Novel Interleukin-2 Receptor Subunit Detected by Cross-Linking Under High-Affinity ConditionsScience, 1986
- The T3 complex on human thymus‐derived lymphocytes contains two different subunits of 20 kDaEuropean Journal of Immunology, 1983
- A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptorNature, 1982
- T cell growth factor receptors. Quantitation, specificity, and biological relevanceThe Journal of Experimental Medicine, 1981
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970